Papers

4

Total Citations

28

H-Index

2

About

Dr. Dhaval Jivanji is a urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in robotic-assisted oncology. His primary research areas include optimizing perioperative care, reducing hospital stays, and improving cost-effectiveness in urologic cancer surgery. Dr. Jivanji is a leading voice on same-day discharge (SDD) after robotic procedures, with his most-cited paper, "Same-Day Discharge After Robot-Assisted Partial Nephrectomy: Is It Worth It?" (2022, 18 citations), demonstrating that SDD is both safe and economically beneficial. He further validated this approach for radical prostatectomy with pelvic lymph node dissection (2024, 6 citations), challenging traditional inpatient protocols. His work on readmissions after radical nephrectomy (2023, 2 citations) uses national cohort data to identify risk factors and financial burdens, informing quality improvement. Dr. Jivanji also explores complex palliative reconstruction, as in his report on robotic distal ureterectomy for metastatic melanoma (2022, 2 citations). By systematically proving the feasibility and value of outpatient robotic surgery, Dr. Jivanji is reshaping recovery pathways, reducing healthcare costs, and enhancing patient quality of life—making him a key innovator in modern urologic oncology.

Research Focus

Key Achievements

2
H-Index
4
Papers
28
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Same-Day Discharge After Robot-Assisted Partial Nephrectomy: Is It Worth It?
18 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Maimonides Medical Center, Florida International University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago